Literature DB >> 12452430

The human steroid hydroxylases CYP1B1 and CYP11B2.

Matthias Bureik1, Michael Lisurek, Rita Bernhardt.   

Abstract

Major advances have been made during the last decade in our understanding of adrenal steroid hormone biosynthesis. Two key players in these pathways are the human mitochondrial cytochrome P450 enzymes CYP11B1 and CYP11B2, which catalyze the final steps in the biosynthesis of cortisol and aldosterone. Using data from mutations found in patients suffering from steroid hormone-related diseases, from mutagenesis studies and from the construction of three-dimensional models of these enzymes, structural information could be deduced that provide a clue to the stereo- and regiospecific steroid hydroxylation reactions carried out by these enzymes. In this review, we summarize the current knowledge on the physiological function and the biochemistry of these enzymes. Furthermore, the pharmacological and toxicological importance of these steroid hydroxylases, the means for the identification of their potential inhibitors and possible biotechnological applications are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452430     DOI: 10.1515/BC.2002.174

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  16 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Aldosterone synthase inhibitors.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2013-03-15       Impact factor: 4.345

3.  Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors.

Authors:  Erik L Meredith; Gary Ksander; Lauren G Monovich; Julien P N Papillon; Qian Liu; Karl Miranda; Patrick Morris; Chang Rao; Robin Burgis; Michael Capparelli; Qi-Ying Hu; Alok Singh; Dean F Rigel; Arco Y Jeng; Michael Beil; Fumin Fu; Chii-Whei Hu; Daniel LaSala
Journal:  ACS Med Chem Lett       Date:  2013-10-17       Impact factor: 4.345

4.  Selective Cyp11B1 Inhibitors for the Treatment of Cortisol Dependent Diseases.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2013-03-15       Impact factor: 4.345

5.  11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis.

Authors:  Rafal M Kaminski; Michael A Rogawski
Journal:  Neuropharmacology       Date:  2011-03-31       Impact factor: 5.250

6.  Protein phosphorylation and intermolecular electron transfer: a joint experimental and computational study of a hormone biosynthesis pathway.

Authors:  Andy Zöllner; Melissa A Pasquinelli; Rita Bernhardt; David N Beratan
Journal:  J Am Chem Soc       Date:  2007-03-15       Impact factor: 15.419

7.  A Fungal P450 Enzyme from Thanatephorus cucumeris with Steroid Hydroxylation Capabilities.

Authors:  Wei Lu; Xi Chen; Jinhui Feng; Yun-Juan Bao; Yu Wang; Qiaqing Wu; Dunming Zhu
Journal:  Appl Environ Microbiol       Date:  2018-06-18       Impact factor: 4.792

8.  Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.

Authors:  Hwei-Ming Peng; Chase Barlow; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2018-03-13       Impact factor: 4.292

9.  A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale.

Authors:  Lina Schiffer; Simone Anderko; Anna Hobler; Frank Hannemann; Norio Kagawa; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2015-02-25       Impact factor: 5.328

10.  Gonadal Transcriptome Analysis in Sterile Double Haploid Japanese Flounder.

Authors:  Xiaoyan Zhang; Jilun Hou; Guixing Wang; Hongbo Jiang; Yufen Wang; Zhaohui Sun; Xiufeng Jiang; Qinghai Yu; Haijin Liu
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.